DE69534283D1 - Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe - Google Patents

Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe

Info

Publication number
DE69534283D1
DE69534283D1 DE69534283T DE69534283T DE69534283D1 DE 69534283 D1 DE69534283 D1 DE 69534283D1 DE 69534283 T DE69534283 T DE 69534283T DE 69534283 T DE69534283 T DE 69534283T DE 69534283 D1 DE69534283 D1 DE 69534283D1
Authority
DE
Germany
Prior art keywords
clonic
active ingredients
medicinal product
containing medicinal
delayed active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69534283T
Other languages
English (en)
Other versions
DE69534283T2 (de
Inventor
H Joseph Horacek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/136,309 external-priority patent/US5484607A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69534283D1 publication Critical patent/DE69534283D1/de
Publication of DE69534283T2 publication Critical patent/DE69534283T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69534283T 1993-10-13 1995-01-26 Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe Expired - Lifetime DE69534283T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/136,309 US5484607A (en) 1993-10-13 1993-10-13 Extended release clonidine formulation
PCT/US1995/001029 WO1996022768A1 (en) 1993-10-13 1995-01-26 Extended release clonidine formulation

Publications (2)

Publication Number Publication Date
DE69534283D1 true DE69534283D1 (de) 2005-07-21
DE69534283T2 DE69534283T2 (de) 2006-03-16

Family

ID=26789483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534283T Expired - Lifetime DE69534283T2 (de) 1993-10-13 1995-01-26 Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe

Country Status (6)

Country Link
EP (1) EP0805677B1 (de)
AU (1) AU707843B2 (de)
CA (1) CA2211325C (de)
DE (1) DE69534283T2 (de)
ES (1) ES2245782T3 (de)
WO (1) WO1996022768A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080090546A (ko) * 2006-01-27 2008-10-08 에프. 호프만-라 로슈 아게 Ｃｎｓ 장애 치료용 2-이미다졸의 용도
KR101176699B1 (ko) 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
WO2008052907A1 (en) 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles as modulators of the trace amine associated receptors
CN101535298A (zh) 2006-11-16 2009-09-16 弗·哈夫曼-拉罗切有限公司 取代的4-咪唑类化合物
WO2008071574A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
CA2675221C (en) 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
CA2676944C (en) 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
US20090087490A1 (en) 2007-06-08 2009-04-02 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
CA2691082A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
WO2009003867A1 (en) 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
KR101133862B1 (ko) 2007-07-27 2012-04-06 에프. 호프만-라 로슈 아게 Ｔａａｒ 리간드로서의 2-아제티딘메테인아민 및 2-피롤리딘메테인아민
EP2185502A1 (de) 2007-08-03 2010-05-19 F. Hoffmann-Roche AG Pyridincarboxamid- und benzamidderivate als taar1-liganden
EP2090307A1 (de) * 2008-02-15 2009-08-19 Bone Therapeutics Pharmazeutische Zusammensetzung zur Behandlung oder Verhinderung von Knochengelenkserkrankungen
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CN104352473A (zh) * 2014-11-21 2015-02-18 哈尔滨圣吉药业股份有限公司 一种盐酸可乐定缓释片及其制备方法
LT3430010T (lt) 2016-03-17 2020-10-12 F. Hoffmann-La Roche Ag 5-etil-4-metil-pirazol-3-karboksamido darinys, galintis veikti kaip taar agonistas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6248618A (ja) * 1985-08-27 1987-03-03 Zeria Shinyaku Kogyo Kk 徐放性製剤およびその製造法
JPS62145014A (ja) * 1985-12-18 1987-06-29 Teijin Ltd 活性持続型医薬品製剤
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine

Also Published As

Publication number Publication date
AU5259396A (en) 1996-08-14
AU707843B2 (en) 1999-07-22
CA2211325A1 (en) 1996-08-01
EP0805677A1 (de) 1997-11-12
DE69534283T2 (de) 2006-03-16
CA2211325C (en) 2006-08-15
EP0805677B1 (de) 2005-06-15
ES2245782T3 (es) 2006-01-16
WO1996022768A1 (en) 1996-08-01
EP0805677A4 (de) 1998-05-06

Similar Documents

Publication Publication Date Title
DE69922964D1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
DE69534283D1 (de) Clonidinhaltiges arzneimittel mit verzögerter wirkstoffabgabe
DE69723303D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
DE69003568D1 (de) Arzneimittel mit verzoegerter freigabe.
ATE163539T1 (de) Arzneimittel
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
BR1100329A (pt) Composto e formulação farmacêutica
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
DE3782840D1 (de) Arzneimittel mit verzoegerter freigabe.
BR1100824A (pt) Composto e composição farmacêutica
DE3786481D1 (de) Topische antimikrobielle arzneimittel.
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
EP0645136A3 (de) Pharmazeutisches Präparat des Typs: physiologisch aktive Substanz mit verlängerter Freisetzung.
NO943888D0 (no) Farmasöytisk preparat
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
DE68908354D1 (de) Verpackung fuer arzneimittel.
DE69937891D1 (de) Fluvastatin-arzneimittel mit verzögerter wirkstoffabgabe
DE69813602D1 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
DE69430580D1 (de) Arzneimittel in nahrungsmittelform
EE03015B1 (et) Ravimpreparaat ja selle valmistamise protsess
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
DE69214310D1 (de) Pranoprofen enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe
LV10365A (lv) Cepumi ar augstu graudu saturu
DE68907392D1 (de) Dysmnesie modifizierende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition